Insider Transactions for Apogee Therapeutics, Inc.

Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics, Inc. (APGE), reported several transactions on June 3, 2026. Dambkowski acquired 4,125 shares of Common Stock at a price of $22.86 per share, increasing his post-transaction holdings to 211,148 shares. Concurrently, he disposed of 5,500 shares of Common Stock at $78.71 per share, resulting in 205,648 shares remaining. Additionally, Dambkowski exercised a stock option to acquire 4,125 shares of Common Stock, with the option having a strike price of $22.86 and an exercise date noted by footnote F2. This option exercise resulted in a post-transaction share count of 118,915. One of these transactions was executed under a Rule 10b5-1 trading plan.